CSI Market
Sign In | Register

Inovio Pharmaceuticals Inc (INO) Annual Balance Sheets

Annual · GAAP · USD millions
Access INO quarterly Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Inovio Pharmaceuticals Inc finances operations and invests in assets.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent44.27
Short-term Investments, Total14.24
Cash & Short-term Investments58.00
Accounts receivable0.00
Accounts Receivable, Related Parties, Current0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current2.61
Total Current Assets61.12
Equipment/Property/Plant Net2.53
Goodwill net0.00
Intangible Assets0.00
Other Assets, Noncurrent10.66
Prepaid Expenses And Other Current Assets From Affiliated Entity-
Total Assets74.31
Liabilities
Accounts Payable and Accrued Liabilities, Current LI11.05
Derivative Liability, Current DE29.07
Convertible Debt, Current LO0.00
Other Liabilities, Current3.55
Total Current Liabilities43.67
Convertible Debt LO0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent6.55
OperatingLeaseLiabilityNoncurrent6.55
Accrued Clinical Trial Expense Current0.65
Operating Lease Liability Current2.82
Contract With Customer Liability Noncurrent-
Total Liabilities50.21
Stockholders' Equity
Common Stock Value0.07
Additional Paid In Capital Common Stock1,839.83
Retained Earnings / Accumulated Deficit-1,815.17
Other Equity-0.64
Common Stockholder's Equity24.10
Total Stockholder's Equity24.10
Liabilities & Stockholder's Equity74.31
4 historic quarters locked

Sign in to unlock the full Inovio Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Inovio Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: March 12, 2026
  • Source: ino-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001055726-26-000008

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License